Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions

Fabiana Ciciriello1, Francesco Panariello2, Paola Medino3

  • 1Cystic Fibrosis Center, 'Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy.

Insights

Cystic fibrosis (CF) patients may not experience more severe COVID-19 due to lower ribosomal gene expression, potentially hindering viral replication. This finding offers insights into virus-host interactions in CF populations.

Area of Science:

  • Respiratory viral infections
  • Immunology
  • Genetics

Background:

  • People with cystic fibrosis (pwCF) face increased risk from respiratory viral infections.
  • Understanding COVID-19's impact on pwCF is crucial for managing their health outcomes.

Purpose of the Study:

  • To investigate the consequences of COVID-19 in people with cystic fibrosis (pwCF) compared to non-CF individuals.
  • To analyze virus-host cell interactions in the context of cystic fibrosis and SARS-CoV-2 infection.

Main Methods:

  • Nasopharyngeal swabs were collected from CF and non-CF individuals for SARS-CoV-2 detection.
  • RNA sequencing was used to evaluate gene expression from nasopharyngeal swabs.
  • COVID-19 severity was defined by hospitalization or increased oxygen therapy needs.

Main Results:

  • 171 patients (65 pwCF, 106 non-CF) were included; 15.4% of pwCF and 40.6% of non-CF individuals tested positive for SARS-CoV-2.
  • Host transcriptomics showed downregulated ribosomal genes in CF samples, regardless of SARS-CoV-2 status.
  • Interferon signaling was upregulated in both groups upon SARS-CoV-2 infection, while motile cilia genes were upregulated in non-infected CF samples.

Conclusions:

  • COVID-19 severity in people with cystic fibrosis (CF) does not appear to be greater than in the general population.
  • Lower expression of ribosomal genes in pwCF may reduce protein translation, creating an environment less conducive to viral replication.
  • Intrinsic factors within the CF population might offer protection against severe COVID-19 outcomes.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
238
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
163
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K